Ixiaro®: a new vaccine against Japanese encephalitis

A decade of Japanese encephalitis surveillance in Sarawak, Malaysia: 1997-2006

(2010) See C. Wong et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Japanese Encephalitis Vaccine (Inactivated, Adsorbed) [IXIARO®]

(2009) Sean T. Duggan et al.   DRUGS

IC51 Japanese Encephalitis vaccine

(2009) Herwig Kollaritsch et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Expert Opinion on Vaccination of Travelers Against Japanese Encephalitis

(2009) Gerd D. Burchard et al.   JOURNAL OF TRAVEL MEDICINE

Japanese Encephalitis in Travelers: Review of Cases and Seasonal Risk

(2009) Mads R. Buhl et al.   JOURNAL OF TRAVEL MEDICINE

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study

(2009) Elisabeth Schuller et al.   VACCINE

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study

(2009) A. Kaltenböck et al.   VACCINE

Japanese encephalitis vaccine in travelers

(2008) Tomas Jelinek   Expert Review of Vaccines

Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand

(2008) Ville A. Lehtinen et al.   JOURNAL OF CLINICAL VIROLOGY

Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Trial of the Safety and Tolerability of IC51, an Inactivated Japanese Encephalitis Vaccine

(2008) E. Tauber et al.   JOURNAL OF INFECTIOUS DISEASES

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51

(2008) E. Schuller et al.   VACCINE

Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51

(2008) Elisabeth Schuller et al.   VACCINE